Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-11-006108
Filing Date
2011-09-19
Accepted
2011-09-19 19:19:49
Documents
1
Period of Report
2011-09-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT c66956_4.html 4  
1 OWNERSHIP DOCUMENT c66956_4.xml 4 3539
  Complete submission text file 0000930413-11-006108.txt   5344
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 550 HILLS DRIVE 3RD FLOOR BEDMINSTER NJ 07921
Business Address
Rackear Andrew D. (Reporting) CIK: 0001408617 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12957 | Film No.: 111098275